Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185328
Status:
COMPLETED
Last Update Posted:
2008-12-12
First Post:
2005-09-12
Brief Title:
Efficacy and Tolerability of Angeliq in Thai Women
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
A Multi-Center Open-Label Non-Comparative Study Investigating the Efficacy and Tolerability of Angeliq in Postmenopausal Thai Women With Vasomotor Symptoms Over Three 28-Day Treatment Cycles
Status:
COMPLETED
Status Verified Date:
2008-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety tolerability and efficacy of Angeliq in Thai post menopausal women with hot flushes and other climacteric symptoms
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG Germany
Bayer Schering Pharma AG Germany is the sponsor of the trial
Bayer Schering Pharma AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 309367 | None | None | None |